Fiji vs Guyana: Statin use vs. average non-HDL cholesterol levels

Fiji

3.8

in 2018

Guyana

3.9

in 2018

Fiji rank

6th

Guyana rank

4th

Statin use vs. average non-HDL cholesterol levels over time

Fiji
Guyana

How they compare

Guyana currently reports 3.9 against 3.8 in Fiji, a difference of 0.1.

The two have swapped places 1 time across 39 shared years of data; in 1980 it was Fiji ahead.

Fiji ranks 6th and Guyana ranks 4th of 191 countries.

Individual pages

About this data

Indicator: Statin use vs. average non-HDL cholesterol levels
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 191 places, 7,449 data points, 1980–2018
Last refreshed: 07 August 2026

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.